世界の発熱性好中球減少症市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Febrile Neutropenia Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5738 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、発熱性好中球減少症の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ペグフィルグラスチム、バンコマイシン塩酸塩、フィルグラスチムバイオシミラー、ペグフィルグラスチムバイオシミラー、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・発熱性好中球減少症の市場動向 ・企業の競争状況、市場シェア ・発熱性好中球減少症の種類別市場規模と予測2016-2027（ペグフィルグラスチム、バンコマイシン塩酸塩、フィルグラスチムバイオシミラー、ペグフィルグラスチムバイオシミラー、その他） ・発熱性好中球減少症の用途別市場規模と予測2016-2027（病院、診療所、その他） ・発熱性好中球減少症の北米市場規模2016-2027（アメリカ、カナダ） ・発熱性好中球減少症の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・発熱性好中球減少症のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・発熱性好中球減少症の中南米市場規模2016-2027（メキシコ、ブラジル） ・発熱性好中球減少症の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Xenetic Biosciences, Inc. (XBIO)、Richter Gedeon Nyrt.、Amgen Inc.、Hospira, Inc.、Eli Lilly and Company、USV Private Limited、Aequus BioPharma, Inc.、Taiho Pharmaceutical Co., Ltd.、BeyondSpring Inc.） ・結論

Febrile neutropenia, one of the most severe complications during cancer chemotherapy, is the development of fever with infection signals.

Market Analysis and Insights: Global Febrile Neutropenia Market
The global Febrile Neutropenia market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Febrile Neutropenia market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Febrile Neutropenia market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Febrile Neutropenia market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Febrile Neutropenia market.

Global Febrile Neutropenia Scope and Market Size
Febrile Neutropenia market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Febrile Neutropenia market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Pegfilgrastim
Vancomycin Hydrochloride
Filgrastim Biosimilars
Pegfilgrastim Biosimilars
Others

Segment by Application
Hospitals
Clinics
Others

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Xenetic Biosciences, Inc. (XBIO)
Richter Gedeon Nyrt.
Amgen Inc.
Hospira, Inc.
Eli Lilly and Company
USV Private Limited
Aequus BioPharma, Inc.
Taiho Pharmaceutical Co., Ltd.
BeyondSpring Inc.

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Febrile Neutropenia Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Pegfilgrastim
1.2.3 Vancomycin Hydrochloride
1.2.4 Filgrastim Biosimilars
1.2.5 Pegfilgrastim Biosimilars
1.2.6 Others
1.3 Market by Application
1.3.1 Global Febrile Neutropenia Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Febrile Neutropenia Market Perspective (2016-2027)
2.2 Febrile Neutropenia Growth Trends by Regions
2.2.1 Febrile Neutropenia Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Febrile Neutropenia Historic Market Share by Regions (2016-2021)
2.2.3 Febrile Neutropenia Forecasted Market Size by Regions (2022-2027)
2.3 Febrile Neutropenia Industry Dynamic
2.3.1 Febrile Neutropenia Market Trends
2.3.2 Febrile Neutropenia Market Drivers
2.3.3 Febrile Neutropenia Market Challenges
2.3.4 Febrile Neutropenia Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Febrile Neutropenia Players by Revenue
3.1.1 Global Top Febrile Neutropenia Players by Revenue (2016-2021)
3.1.2 Global Febrile Neutropenia Revenue Market Share by Players (2016-2021)
3.2 Global Febrile Neutropenia Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Febrile Neutropenia Revenue
3.4 Global Febrile Neutropenia Market Concentration Ratio
3.4.1 Global Febrile Neutropenia Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Febrile Neutropenia Revenue in 2020
3.5 Febrile Neutropenia Key Players Head office and Area Served
3.6 Key Players Febrile Neutropenia Product Solution and Service
3.7 Date of Enter into Febrile Neutropenia Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Febrile Neutropenia Breakdown Data by Type
4.1 Global Febrile Neutropenia Historic Market Size by Type (2016-2021)
4.2 Global Febrile Neutropenia Forecasted Market Size by Type (2022-2027)

5 Febrile Neutropenia Breakdown Data by Application
5.1 Global Febrile Neutropenia Historic Market Size by Application (2016-2021)
5.2 Global Febrile Neutropenia Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Febrile Neutropenia Market Size (2016-2027)
6.2 North America Febrile Neutropenia Market Size by Type
6.2.1 North America Febrile Neutropenia Market Size by Type (2016-2021)
6.2.2 North America Febrile Neutropenia Market Size by Type (2022-2027)
6.2.3 North America Febrile Neutropenia Market Size by Type (2016-2027)
6.3 North America Febrile Neutropenia Market Size by Application
6.3.1 North America Febrile Neutropenia Market Size by Application (2016-2021)
6.3.2 North America Febrile Neutropenia Market Size by Application (2022-2027)
6.3.3 North America Febrile Neutropenia Market Size by Application (2016-2027)
6.4 North America Febrile Neutropenia Market Size by Country
6.4.1 North America Febrile Neutropenia Market Size by Country (2016-2021)
6.4.2 North America Febrile Neutropenia Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Febrile Neutropenia Market Size (2016-2027)
7.2 Europe Febrile Neutropenia Market Size by Type
7.2.1 Europe Febrile Neutropenia Market Size by Type (2016-2021)
7.2.2 Europe Febrile Neutropenia Market Size by Type (2022-2027)
7.2.3 Europe Febrile Neutropenia Market Size by Type (2016-2027)
7.3 Europe Febrile Neutropenia Market Size by Application
7.3.1 Europe Febrile Neutropenia Market Size by Application (2016-2021)
7.3.2 Europe Febrile Neutropenia Market Size by Application (2022-2027)
7.3.3 Europe Febrile Neutropenia Market Size by Application (2016-2027)
7.4 Europe Febrile Neutropenia Market Size by Country
7.4.1 Europe Febrile Neutropenia Market Size by Country (2016-2021)
7.4.2 Europe Febrile Neutropenia Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Febrile Neutropenia Market Size (2016-2027)
8.2 Asia-Pacific Febrile Neutropenia Market Size by Type
8.2.1 Asia-Pacific Febrile Neutropenia Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Febrile Neutropenia Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Febrile Neutropenia Market Size by Type (2016-2027)
8.3 Asia-Pacific Febrile Neutropenia Market Size by Application
8.3.1 Asia-Pacific Febrile Neutropenia Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Febrile Neutropenia Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Febrile Neutropenia Market Size by Application (2016-2027)
8.4 Asia-Pacific Febrile Neutropenia Market Size by Region
8.4.1 Asia-Pacific Febrile Neutropenia Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Febrile Neutropenia Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Febrile Neutropenia Market Size (2016-2027)
9.2 Latin America Febrile Neutropenia Market Size by Type
9.2.1 Latin America Febrile Neutropenia Market Size by Type (2016-2021)
9.2.2 Latin America Febrile Neutropenia Market Size by Type (2022-2027)
9.2.3 Latin America Febrile Neutropenia Market Size by Type (2016-2027)
9.3 Latin America Febrile Neutropenia Market Size by Application
9.3.1 Latin America Febrile Neutropenia Market Size by Application (2016-2021)
9.3.2 Latin America Febrile Neutropenia Market Size by Application (2022-2027)
9.3.3 Latin America Febrile Neutropenia Market Size by Application (2016-2027)
9.4 Latin America Febrile Neutropenia Market Size by Country
9.4.1 Latin America Febrile Neutropenia Market Size by Country (2016-2021)
9.4.2 Latin America Febrile Neutropenia Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Febrile Neutropenia Market Size (2016-2027)
10.2 Middle East & Africa Febrile Neutropenia Market Size by Type
10.2.1 Middle East & Africa Febrile Neutropenia Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Febrile Neutropenia Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Febrile Neutropenia Market Size by Type (2016-2027)
10.3 Middle East & Africa Febrile Neutropenia Market Size by Application
10.3.1 Middle East & Africa Febrile Neutropenia Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Febrile Neutropenia Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Febrile Neutropenia Market Size by Application (2016-2027)
10.4 Middle East & Africa Febrile Neutropenia Market Size by Country
10.4.1 Middle East & Africa Febrile Neutropenia Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Febrile Neutropenia Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Xenetic Biosciences, Inc. (XBIO)
11.1.1 Xenetic Biosciences, Inc. (XBIO) Company Details
11.1.2 Xenetic Biosciences, Inc. (XBIO) Business Overview
11.1.3 Xenetic Biosciences, Inc. (XBIO) Febrile Neutropenia Introduction
11.1.4 Xenetic Biosciences, Inc. (XBIO) Revenue in Febrile Neutropenia Business (2016-2021)
11.1.5 Xenetic Biosciences, Inc. (XBIO) Recent Development
11.2 Richter Gedeon Nyrt.
11.2.1 Richter Gedeon Nyrt. Company Details
11.2.2 Richter Gedeon Nyrt. Business Overview
11.2.3 Richter Gedeon Nyrt. Febrile Neutropenia Introduction
11.2.4 Richter Gedeon Nyrt. Revenue in Febrile Neutropenia Business (2016-2021)
11.2.5 Richter Gedeon Nyrt. Recent Development
11.3 Amgen Inc.
11.3.1 Amgen Inc. Company Details
11.3.2 Amgen Inc. Business Overview
11.3.3 Amgen Inc. Febrile Neutropenia Introduction
11.3.4 Amgen Inc. Revenue in Febrile Neutropenia Business (2016-2021)
11.3.5 Amgen Inc. Recent Development
11.4 Hospira, Inc.
11.4.1 Hospira, Inc. Company Details
11.4.2 Hospira, Inc. Business Overview
11.4.3 Hospira, Inc. Febrile Neutropenia Introduction
11.4.4 Hospira, Inc. Revenue in Febrile Neutropenia Business (2016-2021)
11.4.5 Hospira, Inc. Recent Development
11.5 Eli Lilly and Company
11.5.1 Eli Lilly and Company Company Details
11.5.2 Eli Lilly and Company Business Overview
11.5.3 Eli Lilly and Company Febrile Neutropenia Introduction
11.5.4 Eli Lilly and Company Revenue in Febrile Neutropenia Business (2016-2021)
11.5.5 Eli Lilly and Company Recent Development
11.6 USV Private Limited
11.6.1 USV Private Limited Company Details
11.6.2 USV Private Limited Business Overview
11.6.3 USV Private Limited Febrile Neutropenia Introduction
11.6.4 USV Private Limited Revenue in Febrile Neutropenia Business (2016-2021)
11.6.5 USV Private Limited Recent Development
11.7 Aequus BioPharma, Inc.
11.7.1 Aequus BioPharma, Inc. Company Details
11.7.2 Aequus BioPharma, Inc. Business Overview
11.7.3 Aequus BioPharma, Inc. Febrile Neutropenia Introduction
11.7.4 Aequus BioPharma, Inc. Revenue in Febrile Neutropenia Business (2016-2021)
11.7.5 Aequus BioPharma, Inc. Recent Development
11.8 Taiho Pharmaceutical Co., Ltd.
11.8.1 Taiho Pharmaceutical Co., Ltd. Company Details
11.8.2 Taiho Pharmaceutical Co., Ltd. Business Overview
11.8.3 Taiho Pharmaceutical Co., Ltd. Febrile Neutropenia Introduction
11.8.4 Taiho Pharmaceutical Co., Ltd. Revenue in Febrile Neutropenia Business (2016-2021)
11.8.5 Taiho Pharmaceutical Co., Ltd. Recent Development
11.9 BeyondSpring Inc.
11.9.1 BeyondSpring Inc. Company Details
11.9.2 BeyondSpring Inc. Business Overview
11.9.3 BeyondSpring Inc. Febrile Neutropenia Introduction
11.9.4 BeyondSpring Inc. Revenue in Febrile Neutropenia Business (2016-2021)
11.9.5 BeyondSpring Inc. Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Febrile Neutropenia Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Pegfilgrastim
Table 3. Key Players of Vancomycin Hydrochloride
Table 4. Key Players of Filgrastim Biosimilars
Table 5. Key Players of Pegfilgrastim Biosimilars
Table 6. Key Players of Others
Table 7. Global Febrile Neutropenia Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Febrile Neutropenia Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Febrile Neutropenia Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Febrile Neutropenia Market Share by Regions (2016-2021)
Table 11. Global Febrile Neutropenia Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Febrile Neutropenia Market Share by Regions (2022-2027)
Table 13. Febrile Neutropenia Market Trends
Table 14. Febrile Neutropenia Market Drivers
Table 15. Febrile Neutropenia Market Challenges
Table 16. Febrile Neutropenia Market Restraints
Table 17. Global Febrile Neutropenia Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Febrile Neutropenia Market Share by Players (2016-2021)
Table 19. Global Top Febrile Neutropenia Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Febrile Neutropenia as of 2020)
Table 20. Ranking of Global Top Febrile Neutropenia Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Febrile Neutropenia Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Febrile Neutropenia Product Solution and Service
Table 24. Date of Enter into Febrile Neutropenia Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Febrile Neutropenia Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Febrile Neutropenia Revenue Market Share by Type (2016-2021)
Table 28. Global Febrile Neutropenia Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Febrile Neutropenia Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Febrile Neutropenia Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Febrile Neutropenia Revenue Market Share by Application (2016-2021)
Table 32. Global Febrile Neutropenia Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Febrile Neutropenia Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Febrile Neutropenia Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Febrile Neutropenia Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Febrile Neutropenia Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Febrile Neutropenia Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Febrile Neutropenia Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Febrile Neutropenia Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Febrile Neutropenia Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Febrile Neutropenia Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Febrile Neutropenia Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Febrile Neutropenia Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Febrile Neutropenia Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Febrile Neutropenia Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Febrile Neutropenia Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Febrile Neutropenia Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Febrile Neutropenia Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Febrile Neutropenia Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Febrile Neutropenia Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Febrile Neutropenia Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Febrile Neutropenia Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Febrile Neutropenia Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Febrile Neutropenia Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Febrile Neutropenia Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Febrile Neutropenia Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Febrile Neutropenia Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Febrile Neutropenia Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Febrile Neutropenia Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Febrile Neutropenia Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Febrile Neutropenia Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Febrile Neutropenia Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Febrile Neutropenia Market Size by Country (2022-2027) & (US$ Million)
Table 64. Xenetic Biosciences, Inc. (XBIO) Company Details
Table 65. Xenetic Biosciences, Inc. (XBIO) Business Overview
Table 66. Xenetic Biosciences, Inc. (XBIO) Febrile Neutropenia Product
Table 67. Xenetic Biosciences, Inc. (XBIO) Revenue in Febrile Neutropenia Business (2016-2021) & (US$ Million)
Table 68. Xenetic Biosciences, Inc. (XBIO) Recent Development
Table 69. Richter Gedeon Nyrt. Company Details
Table 70. Richter Gedeon Nyrt. Business Overview
Table 71. Richter Gedeon Nyrt. Febrile Neutropenia Product
Table 72. Richter Gedeon Nyrt. Revenue in Febrile Neutropenia Business (2016-2021) & (US$ Million)
Table 73. Richter Gedeon Nyrt. Recent Development
Table 74. Amgen Inc. Company Details
Table 75. Amgen Inc. Business Overview
Table 76. Amgen Inc. Febrile Neutropenia Product
Table 77. Amgen Inc. Revenue in Febrile Neutropenia Business (2016-2021) & (US$ Million)
Table 78. Amgen Inc. Recent Development
Table 79. Hospira, Inc. Company Details
Table 80. Hospira, Inc. Business Overview
Table 81. Hospira, Inc. Febrile Neutropenia Product
Table 82. Hospira, Inc. Revenue in Febrile Neutropenia Business (2016-2021) & (US$ Million)
Table 83. Hospira, Inc. Recent Development
Table 84. Eli Lilly and Company Company Details
Table 85. Eli Lilly and Company Business Overview
Table 86. Eli Lilly and Company Febrile Neutropenia Product
Table 87. Eli Lilly and Company Revenue in Febrile Neutropenia Business (2016-2021) & (US$ Million)
Table 88. Eli Lilly and Company Recent Development
Table 89. USV Private Limited Company Details
Table 90. USV Private Limited Business Overview
Table 91. USV Private Limited Febrile Neutropenia Product
Table 92. USV Private Limited Revenue in Febrile Neutropenia Business (2016-2021) & (US$ Million)
Table 93. USV Private Limited Recent Development
Table 94. Aequus BioPharma, Inc. Company Details
Table 95. Aequus BioPharma, Inc. Business Overview
Table 96. Aequus BioPharma, Inc. Febrile Neutropenia Product
Table 97. Aequus BioPharma, Inc. Revenue in Febrile Neutropenia Business (2016-2021) & (US$ Million)
Table 98. Aequus BioPharma, Inc. Recent Development
Table 99. Taiho Pharmaceutical Co., Ltd. Company Details
Table 100. Taiho Pharmaceutical Co., Ltd. Business Overview
Table 101. Taiho Pharmaceutical Co., Ltd. Revenue in Febrile Neutropenia Business (2016-2021) & (US$ Million)
Table 102. Taiho Pharmaceutical Co., Ltd. Recent Development
Table 103. BeyondSpring Inc. Company Details
Table 104. BeyondSpring Inc. Business Overview
Table 105. BeyondSpring Inc. Febrile Neutropenia Product
Table 106. BeyondSpring Inc. Revenue in Febrile Neutropenia Business (2016-2021) & (US$ Million)
Table 107. BeyondSpring Inc. Recent Development
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Febrile Neutropenia Market Share by Type: 2020 VS 2027
Figure 2. Pegfilgrastim Features
Figure 3. Vancomycin Hydrochloride Features
Figure 4. Filgrastim Biosimilars Features
Figure 5. Pegfilgrastim Biosimilars Features
Figure 6. Others Features
Figure 7. Global Febrile Neutropenia Market Share by Application: 2020 VS 2027
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Others Case Studies
Figure 11. Febrile Neutropenia Report Years Considered
Figure 12. Global Febrile Neutropenia Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Febrile Neutropenia Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Febrile Neutropenia Market Share by Regions: 2020 VS 2027
Figure 15. Global Febrile Neutropenia Market Share by Regions (2022-2027)
Figure 16. Global Febrile Neutropenia Market Share by Players in 2020
Figure 17. Global Top Febrile Neutropenia Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Febrile Neutropenia as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Febrile Neutropenia Revenue in 2020
Figure 19. Global Febrile Neutropenia Revenue Market Share by Type (2016-2021)
Figure 20. Global Febrile Neutropenia Revenue Market Share by Type (2022-2027)
Figure 21. North America Febrile Neutropenia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Febrile Neutropenia Market Share by Type (2016-2027)
Figure 23. North America Febrile Neutropenia Market Share by Application (2016-2027)
Figure 24. North America Febrile Neutropenia Market Share by Country (2016-2027)
Figure 25. United States Febrile Neutropenia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Febrile Neutropenia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Febrile Neutropenia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Febrile Neutropenia Market Share by Type (2016-2027)
Figure 29. Europe Febrile Neutropenia Market Share by Application (2016-2027)
Figure 30. Europe Febrile Neutropenia Market Share by Country (2016-2027)
Figure 31. Germany Febrile Neutropenia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Febrile Neutropenia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Febrile Neutropenia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Febrile Neutropenia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Febrile Neutropenia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Febrile Neutropenia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Febrile Neutropenia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Febrile Neutropenia Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Febrile Neutropenia Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Febrile Neutropenia Market Share by Region (2016-2027)
Figure 41. China Febrile Neutropenia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Febrile Neutropenia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Febrile Neutropenia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Febrile Neutropenia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Febrile Neutropenia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Febrile Neutropenia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Febrile Neutropenia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Febrile Neutropenia Market Share by Type (2016-2027)
Figure 49. Latin America Febrile Neutropenia Market Share by Application (2016-2027)
Figure 50. Latin America Febrile Neutropenia Market Share by Country (2016-2027)
Figure 51. Mexico Febrile Neutropenia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Febrile Neutropenia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Febrile Neutropenia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Febrile Neutropenia Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Febrile Neutropenia Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Febrile Neutropenia Market Share by Country (2016-2027)
Figure 57. Turkey Febrile Neutropenia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Febrile Neutropenia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Febrile Neutropenia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Xenetic Biosciences, Inc. (XBIO) Revenue Growth Rate in Febrile Neutropenia Business (2016-2021)
Figure 61. Richter Gedeon Nyrt. Revenue Growth Rate in Febrile Neutropenia Business (2016-2021)
Figure 62. Amgen Inc. Revenue Growth Rate in Febrile Neutropenia Business (2016-2021)
Figure 63. Hospira, Inc. Revenue Growth Rate in Febrile Neutropenia Business (2016-2021)
Figure 64. Eli Lilly and Company Revenue Growth Rate in Febrile Neutropenia Business (2016-2021)
Figure 65. USV Private Limited Revenue Growth Rate in Febrile Neutropenia Business (2016-2021)
Figure 66. Aequus BioPharma, Inc. Revenue Growth Rate in Febrile Neutropenia Business (2016-2021)
Figure 67. Taiho Pharmaceutical Co., Ltd. Revenue Growth Rate in Febrile Neutropenia Business (2016-2021)
Figure 68. BeyondSpring Inc. Revenue Growth Rate in Febrile Neutropenia Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

---